Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Toripalimab for Patients With Recurrent Malignant Lymphoma
Clinical trial NCT03316144 · COMPLETED
Trial details
- NCT number
- NCT03316144
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-12
- Primary completion
- 2018-09-15
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.